糖尿病视网膜病变炎症机制研究进展

张 妍1, 马 晓梅2
1、青海大学研究生院
2、青海大学附属医院内分泌科

摘要


糖尿病视网膜病变（Diabetic Retinopathy，DR）是糖尿病患者最为常见的微血管并发症之一，也是致盲的
主要原因。炎症反应在糖尿病视网膜病变的发生和发展过程中扮演关键角色。炎症因子的异常表达与调控，以及炎
症细胞的浸润和激活会影响视网膜的结构与功能，破坏血-视网膜屏障并促成神经元损伤。本文主要从炎症反应相
关角度对糖尿病视网膜病变的发生发展展开论述，旨在为DR的防治提供新的思路和参考。

关键词


糖尿病视网膜病变；炎症机制；信号通路；临床治疗

全文:

PDF


参考


[1]Ramos H, Hernández C, Simó R, et al.

Inflammation: The Link between Neural and Vascular

Impairment in the Diabetic Retina and Therapeutic

Implications. Int J Mol Sci. 2023;24(10):8796.

[2]Tang L, Xu GT, Zhang JF. Inflammation in diabetic

retinopathy: possible roles in pathogenesis and potential

implications for therapy. Neural Regen Res. 2023;18(5):976-982.

[3]Biswas A, Choudhury AD, Agrawal S, et al. Recent

Insights into the Etiopathogenesis of Diabetic Retinopathy and

Its Management. J Ocul Pharmacol Ther. 2024;40(1):13-33.

[4]Chiara Bianca Maria Platania, Gian Marco Leggio,

Salvatore Salomone, et al. Innovativeapproaches to identify

new pharmacological targets for diabetic retinopathy[J]. Journal

ofOcular Pharmacology and Therapeutics, 2023, 39(8).

[5]Luo Y, Li C. Advances in Research Related to

MicroRNA for Diabetic Retinopathy. J Diabetes Res.

2024;2024:8520489.

[6]Jiajian Guo, Qingqing Yu, Genlan Yang, et al.

Neuroprotective effects of etanercept on diabetic retinopathyvia regulation of the TNF-α/NF-κB signaling pathway[J].

Tropical Journal of Pharmaceutical Research, 2022; 21 (10):

2077-2083

[7]Kovoor E, Chauhan SK, Hajrasouliha A. Role of

inflammatory cells in pathophysiology and management of

diabetic retinopathy. Surv Ophthalmol. 2022;67(6):1563-1573.

[8]杨可来尔，匡洪宇.糖尿病视网膜病变与NLRP3

炎性小体[J].国际内分泌代谢杂志，2023，43（2）：

[9]黄丹，邓芳祝，谢功泽，等.转录因子SP1调控

MAP3K1表达影响糖尿病视网膜病变细胞凋亡和炎症反

应[J].中国免疫学杂志，2024，40（3）：519-523.024.

[10]Bikbova G, Oshitari T, Bikbov M. Diabetic

Neuropathy of the Retina and Inflammation: Perspectives. Int

J Mol Sci. 2023;24(11):9166.

[11]汪涛，范隆华，陈斌，等.NLRP3-NF-κB炎

症信号通路在糖尿病足伤口细胞焦亡中的作用研究[J].中

国现代普通外科进展，2022，25（10）：795-799.

[12]Palazzo I, Kelly L, Koenig L, Fischer AJ. Patterns of

NFkB activation resulting from damage, reactive microglia,

cytokines, and growth factors in the mouse retina. Exp

Neurol. 2023;359:114233.

[13]Cho CH, Roh KH, Lim NY, et al. Role of the

JAK/STAT pathway in a streptozotocin-induced diabetic

retinopathy mouse model.[J]. Graefe's archive for clinical and

experimental ophthalmology = Albrecht von Graefes Archiv fur

klinische und experimentelle Ophthalmologie, 2022, 260(11).

[14]Xiao R, Lei C, Zhang Y, Zhang M. Interleukin-6

in retinal diseases: From pathogenesis to therapy. Exp Eye

Res. 2023;233:109556.

[15]Lee MY, Park S, Song JY, et al. Inflammatory

cytokines and retinal nonperfusion area in quiescent

proliferative diabetic retinopathy.[J]. Cytokine, 2022, 154.

[16]Ferreira LB, Williams KA, Best G, et al.

Inflammatory cytokines as mediators of retinalendothelial

barrier dysfunction in non-infectious uveitis. Clin Transl

Immunology. 2023 Dec 12;12(12):e1479.

[17]任芳芳，陈菲，付群，等.糖尿病视网膜病变患

者疾病进展与房水细胞因子的相关性研究[J].眼科新进

展，2024，44（6）：464-469.

[18]郑雅琴，陈继东，曾明星，等.糖尿病视网膜病

变炎症机制与中药提取物干预的研究进展[J].现代中西医

结合杂志，2022，31（14）：2029-2035.


Refbacks

  • 当前没有refback。